At Bantam Pharmaceutical, we are developing novel, first-in-class small molecule oral therapeutics for difficult-to-treat hematological and solid tumors.
Our mission is to destroy cancer cells from the inside, using our unique expertise to alter their inner mitochondrial dynamics.
Our lead candidate is BTM-3566, an orally-available novel small molecule compound with broad anti-cancer activity in hematologic and solid tumors, initially focused on Diffuse Large B-cell Lymphomas (DLBCL).

Our Strategy

We are leveraging our science across two workstreams:
  1. BTM-3566: We are progressing our lead candidate into the clinic
  2. Discovery: We are uncovering other potential small molecules with applications in oncology
Our strategy will enable us to develop a pipeline of future indications in selected solid and hematological tumors, opening the door to new compounds and patient populations experiencing severe unmet need.
LEARN MORE
Bantam Partners

Our Story

We are a private biotechnology company based in Research Triangle Park, North Carolina, USA.

BANTAM FOUNDED

2015
Bantam founded based on acquired Harvard IP

COMPANY PIVOTS

2017
Company switches focus to mitochondrial dynamics, as new insights provide our direction for the future

BTM-3566 IDENTIFIED

2019
BTM-3566 identified as our first clinical candidate, with an initial focus in lymphoma

CMC CAMPAIGN

2020
CMC campaign and initiation of IND enabling studies

Move to IND

2021 - 2022
Ph 1a/1b with evidence of clinical efficacy
LEARN MORE

Learn more about Bantam

We are an early mover in the field of mitochondrial homeostasis, using our pioneering science and unrivaled expertise in mitochondrial cellular biology to revolutionize oncology
We are seeking partners and additional investors to accelerate our clinical research and help bring novel cancer therapies closer to patients in need
Find Out More
Bantam is seeking partners and investors to drive rapid clinical development of our first-in-class molecule from First in Humans trials to clinical Proof of Concept.
CONTACT US
info@bantampharma.com
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram